News Desk :
The Oxford-AstraZeneca Covid-19 vaccine is expected to be approved for use in the UK soon after Christmas.
According to senior government officials, the Medicines and Healthcare products Regulatory Agency (MHRA) is likely to authorize the vaccine on December 28 or 29, reports the Daily Mail.
The organization is now awaiting the final data regarding the vaccine from Oxford University scientists, which will be provided on Monday.
A spokesperson of the MHRA said its analysis was ongoing and he did not contradict the reported timeframe of the approval.
Over 140,000 citizens of Great Britain have already been inoculated with the Pfizer-BioNTech Covid-19 vaccine after it was cleared by the MHRA earlier this month. It has to be stored at -70°C±10°C, whereas the Oxford vaccine can be kept at room temperature.
Also read – Switzerland approves use of Covid-19 vaccine by Pfizer-BioNTech
Jeremy Hunt, former health secretary, warned on Saturday that the remaining doses of the Pfizer-BioNTech vaccine would be used up in January and another batch was not expected until March, which means that the inoculation program could come to a standstill.
The Oxford vaccine would make a massive difference, he said.
Once the MHRA okays the Oxford vaccine, football stadiums and race courses across Great Britain will open from the first week of next year to allow mass inoculation, as reported by The Daily Telegraph.
The Oxford-AstraZeneca Covid-19 vaccine is expected to be approved for use in the UK soon after Christmas.
According to senior government officials, the Medicines and Healthcare products Regulatory Agency (MHRA) is likely to authorize the vaccine on December 28 or 29, reports the Daily Mail.
The organization is now awaiting the final data regarding the vaccine from Oxford University scientists, which will be provided on Monday.
A spokesperson of the MHRA said its analysis was ongoing and he did not contradict the reported timeframe of the approval.
Over 140,000 citizens of Great Britain have already been inoculated with the Pfizer-BioNTech Covid-19 vaccine after it was cleared by the MHRA earlier this month. It has to be stored at -70°C±10°C, whereas the Oxford vaccine can be kept at room temperature.
Also read – Switzerland approves use of Covid-19 vaccine by Pfizer-BioNTech
Jeremy Hunt, former health secretary, warned on Saturday that the remaining doses of the Pfizer-BioNTech vaccine would be used up in January and another batch was not expected until March, which means that the inoculation program could come to a standstill.
The Oxford vaccine would make a massive difference, he said.
Once the MHRA okays the Oxford vaccine, football stadiums and race courses across Great Britain will open from the first week of next year to allow mass inoculation, as reported by The Daily Telegraph.
Consequently, at least 20 million of the most vulnerable citizens of the country could be vaccinated by March, which could pave the way for some restrictions to be eased.
The UK has ordered 100 million doses of the Oxford-AstraZeneca vaccine.
Many other countries which have ordered the Oxford vaccine will receive a morale boost if the MHRA, an executive agency of the Department of Health and Social Care of the UK, approves the jab.
